The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Regional differences in the treatment approaches for relapsed multiple myeloma: An IMF study.
Brian G. Durie
Honoraria - Celgene; Millennium; Onyx
Philippe Moreau
Honoraria - Celgene; Janssen-Cilag; Millennium
Pieter Sonneveld
Honoraria - Celgene; Janssen-Cilag; Millennium; Onyx
Research Funding - Celgene; Janssen-Cilag; Millennium; Onyx
Gareth J Morgan
Honoraria - Celgene; Janssen-Cilag; MSD
Juan José Lahuerta
Consultant or Advisory Role - Celgene; Janssen-Cilag
Meral Beksac
Honoraria - Celgene; Janssen-Cilag
Evangelos Terpos
Honoraria - Celgene; Janssen-Cilag
Research Funding - Celgene; Janssen-Cilag
Roman Hajek
Honoraria - Celgene; Janssen-Cilag
Vânia Tietsche de Moraes Hungria
No relevant relationships to disclose
Angelo Maiolino
No relevant relationships to disclose
WeeJoo Chng
Honoraria - Celgene; Janssen-Ortho; Novartis; Sanofi
Research Funding - Roche
Jae Hoon Lee
No relevant relationships to disclose
Hou Jian
Consultant or Advisory Role - Novartis
Honoraria - Celgene; Janssen-Cilag; Novartis; Roche
Paul Gerard Guy Richardson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Millennium; Novartis
Wenming Chen
No relevant relationships to disclose
Stefan Knop
Consultant or Advisory Role - Celgene; Janssen-Cilag; Mundipharma
Honoraria - Celgene; Janssen-Cilag; Mundipharma
Antje Hoerring
No relevant relationships to disclose
Xavier Leleu
Honoraria - Celgene; Janssen-Cilag
Research Funding - Celgene; Janssen-Cilag
Jesùs F. San-Miguel
Honoraria - Celgene; Janssen-Ortho; Millennium
Shaji Kumar
Consultant or Advisory Role - Merck (U)
Research Funding - Celgene; Cephalon; Genzyme; Millennium; Novartis